This topic contains a solution. Click here to go to the answer

Author Question: Researchers consult with a(n) __________ when there is a question about potential risk or harm to ... (Read 93 times)

fasfsadfdsfa

  • Hero Member
  • *****
  • Posts: 554
Researchers consult with a(n) __________ when there is a question about potential risk or harm to participants.
 
  Fill in the blanks with correct word

Question 2

__________ experimental design has random assignment, a pretest and a post test, an experimental group, and a control group.
 
  Fill in the blanks with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

upturnedfurball

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

IRB

Answer to Question 2

Classical




fasfsadfdsfa

  • Member
  • Posts: 554
Reply 2 on: Jul 13, 2018
Great answer, keep it coming :)


jojobee318

  • Member
  • Posts: 298
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library